natgillin/translations-raw huggingface dataset:
The handling of liquid nitrogen should take place in a well-ventilated area. 
Rukovati s tekućim dušikom u dobro ventiliranim prostorijama.
Insert the needle through the stopper of the solvent bag and add slowly and gently the contents of the syringe to the solvent. 
Uvući iglu kroz čep vrećice s otopinom te polako dodati sadržaj brizgalice u otapalo.
After removing the ampoule(s), the remaining ampoules should be put back immediately into the canister in the liquid nitrogen container. 
Nakon izdvajanja ampule-a, ostale ampule odmah vratiti u kontejner s tekućim dušikom.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (0.2 ml) of reconstituted vaccine contains: 
Svaka doza (0,2 ml) rekonstituirane vakcine sadrži: Djelatna tvar:
5 ampoules, each containing 2,000 or 4,000 doses of cell suspension (attached to the cane is a coloured clip displaying the dose; 2,000 doses: salmon-pink coloured clip, and 4,000 doses: yellow coloured clip). 
5 ampula po kutiji, priložene na kutiju je obojana oznaka prikaza doze (2000 doza: rozo obojana oznaka i 4000 doza: žuto obojena oznaka).
Store and transport frozen in liquid nitrogen (-196 °C). 
Čuvati i prenositi zamrznuto u tekućem dušiku (-196 ºC).
Cell-associated live recombinant turkey herpesvirus (strain HVT/ILT-138), expressing the glycoproteins gD and gI of infectious laryngotracheitis virus: 
Živi rekombinirani, stanično vezan herpesvirus pura (soj HVT/ILT -138), koji izražava glikoproteine gD i gI virusa zaraznog laringotraheitisa:
Remove the washing from the ampoule and inject it gently into the solvent bag. 
Vratiti isprano i injicirati polako u vrećicu otapala.
- 400 ml polyethylene or multilayer plastic bags of solvent. 
- 400 ml polietilen ili višeslojne plastične vrećice otapala. - 800 ml polietilen ili višeslojne plastične vrećice otapala.
Store below 25 °C. 
Čuvati ispod 25ºC.
Solvent: Store below 25 °C. 
Otapalo: čuvati ispod 25 °C.
A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. 
odnosno poslije primjene bilo kojeg drugog veterinarsko-medicinskog proizvoda mora donositi od slučaja do slučaja.
Bovine serum Basal medium Dimethyl sulfoxide 
Osnovni medij Dimetil sulfoksid
Store liquid nitrogen container securely in upright position in a clean, dry and well-ventilated room separated from the hatching/chicken room in the hatchery. 
Kontejner: Čuvati kontejner tekućeg dušika na sigurnom mjestu u uspravnom položaju u čistom, suhom i ventiliranom prostoru odvojenu od valioničkog pilićarnika unutar valionice.
PACKAGE LEAFLET: Innovax-ILT suspension and solvent for suspension for injection for chickens 
UPUTA O VMP: Innovax-ILT suspenzija i otapalo za suspenziju za injekciju za piliće
Use solvent (Solvent for cell associated poultry vaccines) for reconstitution. 
Upotrijebite otapalo (Otapalo za stanično vezana cjepiva peradi) za rekonstituciju.
Suspension: 
Doziranje:
NAME OF THE VETERINARY MEDICINAL PRODUCT Innovax-ILT, suspension and solvent for suspension for injection for chickens 
Innovax-ILT, suspenzija i otapalo za suspenziju za injekciju za piliće
STORAGE CONDITIONS Store below 25 °C. 
UVIJETI ČUVANJA Čuvati ispod 25 °C.
The vaccine is a cell-associated live recombinant turkey herpesvirus (HVT) expressing the gD and gI glycoproteins of infectious laryngotracheitis virus. 
Živi rekombinirani, stanično vezan herpesvirus pura (HVT), koji izražava glikoproteine gD i gI virusa zaraznog laringotraheitisa.
In case of an accident to prevent serious wounds by either the liquid nitrogen or the ampoules when removing an ampoule from the canister, hold palm of gloved hand away from body and face. 
Prilikom izdvajanja ampula iz kontejnera u slučaju nezgode s ciljem sprečavanje ozbiljnih ozljeda tekućim dušikom ili ampulama držati dlanove zaštićene rukavicama dalje od tijela i lica.
Before withdrawing ampoules from the liquid nitrogen canister, protective equipment consisting of gloves, long sleeves and a facemask and goggles should be worn. 
Prije vađenja ampule iz kontejnera tekućeg dušika, treba nositi zaštitnu opremu koja se sastoji od gumenih rukavica, dugih rukava i maske za lice sa zaštitnim naočalama.
Special warnings for each target species: Vaccinate healthy one-day-old chicks only. 
: Cijepiti treba samo zdrave jednodnevne piliće.
Subcutaneous use. 
Probavni kazein gušterače
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION After dilution, administer 1 dose of 0.2 ml of vaccine per chicken by subcutaneous injection in the neck. 
Nakon rekonstitucije, upotrijebiti 1 dozu od 0,2 ml cjepiva po piletu subkutanom primjenom u vrat.
4.7 Use during pregnancy, lactation or lay 
4.7 Primjena tijekom graviditeta, laktacije ili nesenja Nema dostupnih informacija za upotrebu kod budućeg rasplodnog jata.
Shelf life of the cell suspension as packaged for sale: 3 years. 
Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju: 3 godine.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE SOLVENT BAG 
OSNOVNI DJELOVI NAPISANI NA MALIM JEDINICAMA UNUTARNJIH PAKOVANJA VREĆICA OTAPALA
ANNEX II A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCES AND> MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION 
PROIZVOĐAČ BIOLOŠKI DJELATNE TVARI I PROIZVOĐAČ ODGOVORAN(I) ZA PUŠTANJE SERIJE U PROMET
Other medicines and Neoclarityn 
Drugi lijekovi i Neoclarityn
A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Neoclarityn therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. 
Potrebno je odlučiti da li prekinuti dojenje ili prekinuti liječenje/suzdržati se od liječenja lijekom Neoclarityn uzimajući u obzir korist dojenja za dijete i korist liječenja za ženu.
Treatment with Neoclarityn also significantly reduced interference with sleep and daytime function, as measured by a four-point scale used to assess these variables. 
Liječenje lijekom Neoclarityn također je značajno smanjilo utjecaj na spavanje i dnevne aktivnosti, što se mjerilo skalom od četiri stupnja za procjenu tih varijabli.
Common in children less than 2 years of age: the following may affect up to 1 in 10 children 
Česte u djece mlađe od 2 godine: sljedeće nuspojave mogu se javiti u do 1 na 10 djece
Talk to your doctor, pharmacist or nurse before taking Neoclarityn: - if you have poor kidney function. 
Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego uzmete Neoclarityn: - ako imate oslabljenu funkciju bubrega.
Use caution when taking Neoclarityn with alcohol. 
Potreban je oprez kada se Neoclarityn uzima s alkoholom.
There are no known interactions of Neoclarityn with other medicines. 
Nema poznatih interakcija između lijeka Neoclarityn i drugih lijekova.
In the case of severe renal insufficiency, Neoclarityn should be used with caution (see section 5.2). 
U slučaju teške insuficijencije bubrega, Neoclarityn treba oprezno primjenjivati (vidjeti dio 5.2).
Neoclarityn tablets effectively controlled symptoms for 24 hours. 
Neoclarityn tablete su učinkovito kontrolirale simptome tijekom 24 sata.
Neoclarityn effectively controlled symptoms for 24 hours. 
Neoclarityn je učinkovito kontrolirao simptome tijekom 24 sata.
However, the safety of desloratadine syrup formulation, which contains the same concentration of desloratadine as Neoclarityn oral solution, was demonstrated in three paediatric trials. 
Međutim, sigurnost primjene desloratadina u obliku sirupa, koji sadrži istu koncentraciju desloratadina kao Neoclarityn oralna otopina, dokazana je u tri pedijatrijska ispitivanja.
What Neoclarityn is Neoclarityn contains desloratadine which is an antihistamine. 
Što je Neoclarityn Neoclarityn sadrži desloratadin, koji je antihistaminik.
The prescriber should be aware that most cases of rhinitis below 2 years of age are of infectious origin (see section 4.4) and there are no data supporting the treatment of infectious rhinitis with Neoclarityn. 
Liječnik koji propisuje lijek treba znati da je većina slučajeva rinitisa u djece mlađe od dvije godine infektivnog podrijetla (vidjeti dio 4.4) te da ne postoje podaci koji podupiru liječenje infektivnog rinitisa lijekom Neoclarityn.
As a precautionary measure, it is preferable to avoid the use of Neoclarityn during pregnancy. 
Kao mjera opreza, preporuča se izbjegavati primjenu lijeka Neoclarityn tijekom trudnoće.
What Neoclarityn is and what it is used for 
Što je Neoclarityn i za što se koristi
During the marketing of Neoclarityn, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) have been reported very rarely. 
Nakon stavljanja u promet lijeka Neoclarityn, slučajevi teških alergijskih reakcija (otežano disanje, zviždanje pri disanju, svrbež, koprivnjača i oticanje) bili su prijavljeni vrlo rijetko.
Therefore, the efficacy of Neoclarityn orodispersible tablet is expected to be the same as with the Neoclarityn tablet formulation. 
Stoga se očekuje da će djelotvornost Neoclarityn raspadljivih tableta za usta biti jednaka kao kod primjene Neoclarityn tableta.
As Neoclarityn oral solution contains the same concentration of desloratadine, no bioequivalence study was required and it is expected to be equivalent to the syrup and tablet. 
Budući da Neoclarityn oralna otopina sadrži jednaku koncentraciju desloratadina, nije bilo potrebno provesti ispitivanje bioekvivalencije sa sirupom i tabletama i očekuje se da su te formulacije ekvivalentne.
1 film-coated tablet 2 film-coated tablets 3 film-coated tablets 5 film-coated tablets 7 film-coated tablets 10 film-coated tablets 14 film-coated tablets 15 film-coated tablets 20 film-coated tablets 21 film-coated tablets 30 film-coated tablets 50 film-coated tablets 100 film-coated tablets 
1 filmom obložena tableta 2 filmom obložene tablete 3 filmom obložene tablete 5 filmom obloženih tableta 7 filmom obloženih tableta 10 filmom obloženih tableta 14 filmom obloženih tableta 15 filmom obloženih tableta 20 filmom obloženih tableta 21 filmom obložena tableta 30 filmom obloženih tableta 50 filmom obloženih tableta 100 filmom obloženih tableta
The efficacy of Neoclarityn tablets has not been clearly demonstrated in trials with adolescent patients 12 through 17 years of age. 
Djelotvornost Neoclarityn tableta još nije jasno dokazana u ispitivanjima na adolescentnim bolesnicima u dobi od 12 do 17 godina.
What Neoclarityn contains 
Što Neoclarityn sadrži
Neoclarityn tablets contain lactose. 
Neoclarityn tablete sadrže laktozu.
In a clinical pharmacology trial, Neoclarityn tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1). 
U kliničkom farmakološkom ispitivanju, uzimanje Neoclarityn tableta istodobno s alkoholom nije pojačalo štetne učinke alkohola na ponašanje (vidjeti dio 5.1).
In two placebo-controlled six week trials in patients with chronic idiopathic urticaria, Neoclarityn was effective in relieving pruritus and decreasing the size and number of hives by the end of the first dosing interval. 
U dva placebom kontrolirana ispitivanja u trajanju od šest tjedana u bolesnika s kroničnom idiopatskom urtikarijom, Neoclarityn je učinkovito ublažavao pruritus i smanjivao veličinu i broj koprivnjača do kraja prvog intervala doziranja.
Neoclarityn orodispersible tablet with food, drink and alcohol Neoclarityn orodispersible tablet does not need to be taken with water or liquid. 
Neoclarityn raspadljive tablete za usta s hranom, pićem i alkoholom Neoclarityn raspadljive tablete za usta ne trebaju se uzimati s vodom ili drugom tekućinom.
Neoclarityn has no or negligible influence on the ability to drive and use machines based on clinical trials. 
Neoclarityn ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
Neoclarityn 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Neoclarityn orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age. 
Neoclarityn 2,5 mg tablete nisu ispitivane u pedijatrijskih bolesnika; međutim, farmakokinetički podaci o Neoclarityn raspadljivim tabletama za usta zajedno s podacima iz pedijatrijskih ispitivanja utvrđivanja doze podupiru primjenu doze od 2,5 mg u pedijatrijskih bolesnika u dobi od 6 do 11 godina.
Efficacy of Neoclarityn oral solution has not been investigated in separate paediatric trials. 
Djelotvornost Neoclarityn oralne otopine nije ispitivana u posebnim pedijatrijskim kliničkim ispitivanjima.
In clinical studies in most children and adults, side effects with Neoclarityn were about the same as with a dummy solution or tablet. 
U kliničkim ispitivanjima u većine djece i odraslih su nuspojave kod primjene lijeka Neoclarityn bile približno iste kao kod uzimanja otopine ili tableta placeba.
Neoclarityn contains lactose 
Neoclarityn sadrži laktozu
Neoclarityn was effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire. 
Neoclarityn je bio učinkovit u ublažavanju simptoma sezonskog alergijskog rinitisa, što se vidi iz ukupnog rezultata upitnika o kvaliteti života ispitanika s rinokonjuktivitisom.
What Neoclarityn is and what it is used for What you need to know before you take Neoclarityn How to take Neoclarityn 
Što je Neoclarityn i za što se koristi Što morate znati prije nego počnete uzimati Neoclarityn Kako uzimati Neoclarityn
Efficacy of Neoclarityn syrup has not been investigated in paediatric trials in children less than 12 years of age. 
Djelotvornost Neoclarityn sirupa nije ispitivana u pedijatrijskim kliničkim ispitivanjima u djece mlađe od 12 godina.
Neoclarityn tablets were effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire. 
Neoclarityn tablete su bile učinkovite u ublažavanju simptoma sezonskog alergijskog rinitisa, što se vidi iz ukupnog rezultata upitnika o kvaliteti života ispitanika s rinokonjuktivitisom.
Adverse reactions seen with Neoclarityn 
Nuspojave opažene uz Neoclarityn
Neoclarityn oral solution with food, drink and alcohol Neoclarityn may be taken with or without a meal. 
Neoclarityn oralna otopina s hranom, pićem i alkoholom Neoclarityn se može uzeti uz ili bez obroka.
How to store Neoclarityn oral solution Contents of the pack and other information 
Kako čuvati Neoclarityn oralnu otopinu Sadržaj pakiranja i druge informacije
In clinical studies with Neoclarityn, the following side effects were reported as: 
U kliničkim ispitivanjima s lijekom Neoclarityn, sljedeće nuspojave bile su prijavljene kao:
If you forget to take Neoclarityn 
Ako ste zaboravili uzeti Neoclarityn
What you need to know before you take Neoclarityn 
Što morate znati prije nego počnete uzimati Neoclarityn
Neoclarityn oral solution contains sorbitol. 
Neoclarityn oralna otopina sadrži sorbitol.
Neoclarityn oral solution contains sorbitol 
Neoclarityn oralna otopina sadrži sorbitol
What Neoclarityn orodispersible tablet is and what it is used for What you need to know before you take Neoclarityn orodispersible tablet How to take Neoclarityn orodispersible tablet Possible side effects 
Što je Neoclarityn raspadljiva tableta za usta i za što se koristi Što morate znati prije nego počnete uzimati Neoclarityn raspadljive tablete za usta Kako uzimati Neoclarityn raspadljive tablete za usta Moguće nuspojave
What Neoclarityn looks like and contents of the pack 
Kako Neoclarityn izgleda i sadržaj pakiranja
Do not use this medicine if you notice any change in the appearance of Neoclarityn orodispersible tablet. 
Ovaj lijek se ne smije upotrijebiti ako primijetite bilo kakvu promjenu izgleda Neoclarityn raspadljivih tableta za usta.
How to store Neoclarityn orodispersible tablet Contents of the pack and other information 
Kako čuvati Neoclarityn raspadljive tablete za usta Sadržaj pakiranja i druge informacije
In single-dose crossover studies of Neoclarityn 5 mg orodispersible tablets with Neoclarityn 5 mg conventional tablets, the formulations were bioequivalent. 
U ispitivanjima naizmjenične primjene jedne doze Neoclarityn 5 mg raspadljivih tableta za usta i konvencionalnih Neoclarityn 5 mg tableta, te su formulacije bile bioekvivalentne.
Children 1 through 5 years of age: 2.5 ml (1.25 mg) Neoclarityn oral solution once a day. 
Djeca u dobi od 1 do 5 godina: 2,5 ml (1,25 mg) Neoclarityn oralne otopine jedanput na dan.
If you take more Neoclarityn oral solution than you should Take Neoclarityn oral solution only as it is prescribed for you. 
Ako uzmete više Neoclarityn oralne otopine nego što ste trebali Uzimajte Neoclarityn oralnu otopinu samo na način kako Vam je propisano.
What Neoclarityn orodispersible tablet is and what it is used for 
Što je Neoclarityn raspadljiva tableta za usta i za što se koristi
Neoclarityn is supplied in blisters comprised of laminate blister film with foil lidding. 
Neoclarityn je dostupan u blisterima, a napravljeni su od laminiranog blister filma prekrivenog folijom.
Neoclarityn 2.5 mg orodispersible tablet is light red, speckled, and round with “K” branded on one side. 
Neoclarityn 2,5 mg raspadljiva tableta za usta je svijetlocrvena, točkasta i okrugla tableta, s oznakom "K" na jednoj strani.
Neoclarityn 5 mg orodispersible tablet is light red, speckled, and round with “A” branded on one side. 
Neoclarityn 5 mg raspadljiva tableta za usta je svijetlocrvena, točkasta i okrugla tableta, s oznakom "A" na jednoj strani.
Adults During the marketing of Neoclarityn, the following side effects were reported as: 
Odrasli Nakon stavljanja u promet lijeka Neoclarityn, sljedeće su nuspojave prijavljene kao:
Neoclarityn 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 or 100 tablets. 
Neoclarityn 5 mg filmom obložene tablete pakirane su u blistere, u veličinama pakiranja od 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 ili 100 tableta.
What you need to know before you take Neoclarityn orodispersible tablet 
Što morate znati prije nego počnete uzimati Neoclarityn raspadljive tablete za usta
Name and address of the manufacturer responsible for batch release for film coated tablets 
Naziv i adresa proizvođača odgovornog za puštanje serije lijeka u promet za filmom obložene tablete
During the marketing of Neoclarityn, the following side effects were reported as: 
Nakon stavljanja u promet lijeka Neoclarityn, sljedeće su nuspojave prijavljene kao:
At the recommended dose, Neoclarityn 5 mg orodispersible tablet was found to be bioequivalent to the Neoclarityn 5 mg conventional tablet formulation of desloratadine. 
Utvrđeno je da je Neoclarityn 5 mg raspadljiva tableta za usta u preporučenoj dozi bioekvivalentna formulaciji desloratadina u obliku konvencionalne Neoclarityn 5 mg tablete.
How to take Neoclarityn 
Kako uzimati Neoclarityn
When Neoclarityn should be used 
Kada treba uzimati Neoclarityn
Adults and adolescents (12 years of age and over) The recommended dose of Neoclarityn is one tablet once a day. 
Odrasli i adolescenti (u dobi od 12 godina i stariji) Preporučena doza lijeka Neoclarityn je jedna tableta jedanput na dan.
Neoclarityn orodispersible tablets are supplied in unit dose blisters comprised of laminate blister film with foil lidding. 
Neoclarityn raspadljive tablete za usta dostupne su u blisterima djeljivima na jedinične doze koji su napravljeni od laminiranog blister filma prekrivenog folijom.
Children 6 to 11 years of age: the recommended dose of Neoclarityn is one 2.5 mg orodispersible tablet placed in mouth once a day. 
Djeca u dobi od 6 do 11 godina: preporučena doza lijeka Neoclarityn je jedna raspadljiva tableta za usta od 2,5 mg koja se stavlja u usta jedanput na dan.
Do not take Neoclarityn - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine. 
Nemojte uzimati Neoclarityn - ako ste alergični na desloratadin, neki drugi sastojak ovog lijeka (naveden u dijelu 6.) ili na loratadin.
What Neoclarityn oral solution contains 
Što Neoclarityn oralna otopina sadrži
This product contains 1.4 mg of phenylalanine per 2.5 mg dose of Neoclarityn orodispersible tablet. 
Ovaj lijek sadrži 1,4 mg fenilalanina po dozi Neoclarityn raspadljive tablete za usta od 2,5 mg.
What Neoclarityn oral solution is and what it is used for 
Što je Neoclarityn oralna otopina i za što se koristi
Water had no effect on the bioavailability of Neoclarityn orodispersible tablets. 
Voda nije utjecala na bioraspoloživost
Neoclarityn is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1) 
Neoclarityn je indiciran u odraslih, adolescenata i djece starije od 1 godine za ublažavanje simptoma povezanih s: - alergijskim rinitisom (vidjeti dio 5.1) - urtikarijom (vidjeti dio 5.1)
This product contains 2.9 mg of phenylalanine per 5 mg dose of Neoclarityn orodispersible tablet. 
Ovaj lijek sadrži 2,9 mg fenilalanina po dozi Neoclarityn raspadljive tablete za usta od 5 mg.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neoclarityn orodispersible tablets. 
Vezano za trajanje liječenja, Vaš će liječnik odrediti od kojeg tipa alergijskog rinitisa bolujete te koliko dugo trebate uzimati Neoclarityn raspadljive tablete za usta.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neoclarityn. 
Vezano za trajanje liječenja, Vaš će liječnik odrediti od kojeg tipa alergijskog rinitisa bolujete te koliko dugo trebate uzimati Neoclarityn.
Neoclarityn 0.5 mg/ml oral solution 
Neoclarityn 0,5 mg/ml oralna otopina
Neoclarityn is an antiallergy medicine that does not make you drowsy. 
Neoclarityn je lijek protiv alergije koji ne izaziva pospanost.
Neoclarityn tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials. 
Neoclarityn tablete primijenjene u jednokratnoj dnevnoj dozi od 7,5 mg odraslima i adolescentima nisu imale učinak na psihomotorne sposobnosti u kliničkim ispitivanjima.
Children 6 through 11 years of age: 5 ml (2.5 mg) Neoclarityn oral solution once a day. 
Djeca u dobi od 6 do 11 godina: 5 ml (2,5 mg) Neoclarityn oralne otopine jedanput na dan.
Neoclarityn orodispersible tablet is an antiallergy medicine that does not make you drowsy. 
Neoclarityn raspadljiva tableta za usta je lijek protiv alergije koji ne izaziva pospanost.
How Neoclarityn works 
Kako djeluje Neoclarityn
Neoclarityn is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). 
Neoclarityn se također koristi za ublažavanje simptoma povezanih s urtikarijom (promjene na koži uslijed alergije).
What Neoclarityn oral solution is and what it is used for What you need to know before you take Neoclarityn oral solution How to take Neoclarityn oral solution Possible side effects 
Što je Neoclarityn oralna otopina i za što se koristi Što morate znati prije nego počnete uzimati Neoclarityn oralnu otopinu Kako uzimati Neoclarityn oralnu otopinu Moguće nuspojave
EU/1/00/161/059 30 ml with 1 spoon EU/1/00/161/060 50 ml with 1 spoon EU/1/00/161/061 60 ml with 1 spoon EU/1/00/161/062 100 ml with 1 spoon EU/1/00/161/063 120 ml with 1 spoon EU/1/00/161/064 150 ml with 1 spoon EU/1/00/161/067 150 ml with 1 oral syringe EU/1/00/161/065 225 ml with 1 spoon EU/1/00/161/066 300 ml with 1 spoon 
EU/1/00/161/059 30 ml s 1 žličicom EU/1/00/161/060 50 ml s 1 žličicom EU/1/00/161/061 60 ml s 1 žličicom EU/1/00/161/062 100 ml s 1 žličicom EU/1/00/161/063 120 ml s 1 žličicom EU/1/00/161/064 150 ml s 1 žličicom EU/1/00/161/067 150 ml s 1 štrcaljkom za usta EU/1/00/161/065 225 ml s 1 žličicom EU/1/00/161/066 300 ml s 1 žličicom
If you forget to take Neoclarityn oral solution 
Ako ste zaboravili uzeti Neoclarityn oralnu otopinu